Skip to main content
. 2020 Aug 31;21(17):6288. doi: 10.3390/ijms21176288

AD
ATIs
Amyloid beta peptide
Alzheimer’s disease
Amylase trypsin inhibitors
CCL2 C–C motif chemokine ligand 2
5xFAD Transgenic AD mouse model with 5 familial mutations
IL1β Interleukin 1 beta
TLR Toll-like receptor